Evommune Announces Late-Breaker Presentation of Phase 2a Data for EVO301 in Atopic Dermatitis at European Academy of Dermatology & Venereology 2026 Congress
Presentation / Abstract • Phase 2Late-breaking oral presentation Thu, Oct 1, 2026, 4:30 PM CEST